-
Soligenix, Inc. (NASDAQ: SNGX) shares climbed
83.6 percent to $4.72. Soligenix reported that results from its ricin toxin vaccine program will be presented at the 20th
Annual Conference on Vaccine Research.
-
Argos Therapeutics Inc (NASDAQ: ARGS) shares
jumped 83.5 percent to $0.718 after the company announced interim results of the Phase 3 ADAPT trial of Rocapuldencel-T and
decision to continue the trial.
-
Entertainment Gaming Asia Inc (NASDAQ: EGT) shares
gained 21.8 percent to $2.01.
-
China Auto Logistics Inc (NASDAQ: CALI) shares
climbed 16.6 percent to $2.88.
-
ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 13.9
percent to $3.69 after gaining 1.89 percent on Tuesday.
-
CalAmp Corp. (NASDAQ: CAMP) shares gained 12.3
percent to $17.86 after the company reported strong Q4 results.
-
Ultragenyx Pharmaceutical Inc (NASDAQ: RARE)
shares gained 9 percent to $65.45 after the company disclosed that Phase 3 study of KRN23 met primary endpoint.
-
Edge Therapeutics Inc (NASDAQ: EDGE) rose 9
percent to $9.60. Edge Therapeutics agreed to sell 1.8 million shares of stock to Satter Medical Technology Partners for $10
per share.
-
Intuitive Surgical, Inc. (NASDAQ: ISRG) shares
climbed 7.2 percent to $813.62 after the company reported stronger-than-expected earnings for its first quarter and raised its
FY17 procedure growth forecast.
-
Lam Research Corporation (NASDAQ: LRCX) rose 6.4
percent to $135.61 after the company posted upbeat quarterly results.
-
Royal Bank of Scotland Group PLC (NYSE: RBS) gained
4 percent to $6.01. JP Morgan upgraded Royal Bank of Scotland from Underweight to Neutral.
-
Genuine Parts Company (NYSE: GPC) rose 3.9 percent
to $93.55 on better-than-expected quarterly earnings.
-
Tempur Sealy International Inc (NYSE: TPX) surged
3.5 percent to $42.26. Raymond James upgraded Tempur Sealy from Outperform to Strong Buy.
-
Southwestern Energy Company (NYSE: SWN) rose 3.4
percent to $7.58. Cowen & Co. upgraded Southwestern Energy from Market Perform to Outperform.
-
Morgan Stanley (NYSE: MS) rose 3 percent to $42.41
after the bank reported stronger-than-expected earnings for its first quarter.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.